Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
An MR Brain Images Classifier System via Particle Swarm Optimization and Kernel Support Vector Machine.
Multiple sclerosis is associated with psoriasis. A case-control study.
IL-27-induced modulation of autoimmunity and its therapeutic potential.
Multicontrast MRI Quantification of Focal Inflammation and Degeneration in Multiple Sclerosis.
Schwann Cell Expressed Nogo-B Modulates Axonal Branching of Adult Sensory Neurons Through the Nogo-B Receptor NgBR.
Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro.
Reducing suffering in experimental autoimmune encephalomyelitis (EAE).
Phonological fluency strategy of switching differentiates relapsing-remitting and secondary progressive multiple sclerosis patients.
Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.
Does giving segmental muscle vibration alter the response to botulinum toxin injections in the treatment of spasticity in people with multiple sclerosis? A single-blind randomized controlled trial.
Diagnosing neuromyelitis optica.
Neurogenic detrusor overactivity: an update on management options.
Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity.
The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort.
Assessment of urinary incontinence in the women in Eastern Turkey.
Evidence for efficacy of a drug widely used without authorisation in multiple sclerosis: mycophenolate mofetil.
Transfer of myelin-reactive th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice.
Management of psoriasis vulgaris and multiple sclerosis with fumaric acid.
Systemic Injection of Low-Dose Lipopolysaccharide Fails to Break down the Blood-Brain Barrier or Activate the TLR4-MyD88 Pathway in Neonatal Rat Brain.
Fostering adherence to injectable disease-modifying therapies in multiple sclerosis.
Neutrophils Amplify Autoimmune Central Nervous System Infiltrates by Maturing Local APCs.
FTY720 inhibits tumor growth and enhances the tumor-suppressive effect of topotecan in neuroblastoma by interfering with the sphingolipid signaling pathway.
Understanding the neurobiology of CD200 and the CD200 receptor: a therapeutic target for controlling inflammation in human brains?
Sequential activation of microglia and astrocyte cytokine expression precedes increased iba-1 or GFAP immunoreactivity following systemic immune challenge.
[Vitamin D in Multiple Sclerosis].
Pages
« first
‹ previous
…
470
471
472
473
474
475
476
477
478
…
next ›
last »